Review: Prostate Cancer Screening Using PSA Does Not Decrease Mortality

ACP Journal Club18 January 2011Review: Prostate cancer screening using PSA does not decrease mortalityRoger Luckmann, MD, MPHRoger Luckmann, MD, MPHUniversity of Massachusetts Medical School, Worcester, Massachusetts, USA (R.L.)Search for more papers by this authorAuthor, Article, and Disclosure Informationhttps://doi.org/10.7326/0003-4819-154-2-201101180-02002 SectionsAboutFull TextPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissions ShareFacebookTwitterLinkedInRedditEmail Source CitationDjulbegovic M, Beyth RJ, Neuberger MM, et al. Screening for prostate cancer: systematic review and meta-analysis of randomised controlled trials. BMJ. 2010;341:c4543. https://pubmed.ncbi.nlm.nih.gov/20843937Clinical Impact RatingsGIM/FP/GP: References1 Hugosson J, Carlsson S, Aus G, et al. Mortality results from the Göteborg randomised population-based prostate-cancer screening trial. Lancet Oncol. 2010;11:725-32. [PMID: 20598634] Google Scholar2 Schröder FH, Hugosson J, Roobol MJ, et al. Screening and prostate-cancer mortality in a randomized European study. N Engl J Med. 2009;360:1320-8. [PMID: 19297566] Google Scholar Author, Article, and Disclosure InformationAffiliations: University of Massachusetts Medical School, Worcester, Massachusetts, USA (R.L.)This article was published at Annals.org on 4 January 2011. PreviousarticleNextarticle Advertisement FiguresReferencesRelatedDetails Metrics 18 January 2011Volume 154, Issue 2Page: JC1-2KeywordsAge distributionAntigensCancer screeningProstate cancerRisk managementSystematic reviews ePublished: 18 January 2011 Issue Published: 18 January 2011 CopyrightCopyright © 2011 by American College of Physicians. All Rights Reserved.PDF DownloadLoading ...